SE0102055D0 - New Compounds - Google Patents

New Compounds

Info

Publication number
SE0102055D0
SE0102055D0 SE0102055A SE0102055A SE0102055D0 SE 0102055 D0 SE0102055 D0 SE 0102055D0 SE 0102055 A SE0102055 A SE 0102055A SE 0102055 A SE0102055 A SE 0102055A SE 0102055 D0 SE0102055 D0 SE 0102055D0
Authority
SE
Sweden
Prior art keywords
new compounds
active compounds
compounds
gaba
solvates
Prior art date
Application number
SE0102055A
Other languages
Swedish (sv)
Inventor
Thomas Elebring
Peter Guzzo
Anders Lehmann
Sverker Von Unge
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0102055A priority Critical patent/SE0102055D0/en
Publication of SE0102055D0 publication Critical patent/SE0102055D0/en
Priority to PCT/SE2002/001086 priority patent/WO2002100871A1/en

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Novel compounds of formula I having affinity to one or more GABA<B? 191 receptors, their pharmaceutically acceptable salts, solvates and stereoisomers, as well as processes for their preparation, pharmaceutical compositions containing said therapeutically active compounds and the use of said active compounds in therapy.
SE0102055A 2001-06-08 2001-06-08 New Compounds SE0102055D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0102055A SE0102055D0 (en) 2001-06-08 2001-06-08 New Compounds
PCT/SE2002/001086 WO2002100871A1 (en) 2001-06-08 2002-06-04 New compounds useful in reflux disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102055A SE0102055D0 (en) 2001-06-08 2001-06-08 New Compounds

Publications (1)

Publication Number Publication Date
SE0102055D0 true SE0102055D0 (en) 2001-06-08

Family

ID=20284430

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102055A SE0102055D0 (en) 2001-06-08 2001-06-08 New Compounds

Country Status (2)

Country Link
SE (1) SE0102055D0 (en)
WO (1) WO2002100871A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236750B2 (en) 2004-08-06 2012-08-07 Nycomed Gmbh Composition comprising a pulmonary surfactant and a TNF-derived peptide
SE0402462D0 (en) * 2004-10-08 2004-10-08 Astrazeneca Ab New process
US7494985B2 (en) 2004-11-03 2009-02-24 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
US7566738B2 (en) 2004-11-03 2009-07-28 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
WO2006071186A1 (en) * 2004-12-27 2006-07-06 Astrazeneca Ab Use of gabab receptor agonists
US20060160777A1 (en) * 2004-12-27 2006-07-20 Anders Lehmann New use of GABAbeta receptor agonists
WO2008033572A1 (en) 2006-09-15 2008-03-20 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
US9139714B2 (en) 2008-11-05 2015-09-22 Clariant Finance (Bvi) Limited Method for producing dialkylphosphinic acids and esters and salts thereof by means of allyl alcohols-acroleins and use thereof
US8664418B2 (en) 2008-11-07 2014-03-04 Clariant Finance (Bvi) Limited Method for producing dialkylphosphinic acids and esters and salts thereof by means of acrylic acid derivatives and use thereof
DE102008056341A1 (en) 2008-11-07 2010-05-12 Clariant International Limited Process for the preparation of mono-amino-functionalized dialkylphosphinic acids, esters and salts by means of acrylonitriles and their use
DE102008060035A1 (en) 2008-12-02 2010-06-10 Clariant International Limited Process for the preparation of monohydroxy-functionalized dialkylphosphinic acids, esters and salts by means of vinyl esters of a carboxylic acid and their use
DE102008060535A1 (en) 2008-12-04 2010-06-10 Clariant International Limited Process for the preparation of mono-carboxy-functionalized dialkylphosphinic acids, esters and salts by means of vinyl ethers and their use
DE102008063668A1 (en) 2008-12-18 2010-07-01 Clariant International Limited Process for the preparation of alkylphosphonic acids, esters and salts by oxidation of alkylphosphonous acids and their use
CN103724372B (en) 2008-12-18 2017-03-01 科莱恩金融(Bvi)有限公司 The purposes of ethylene alkyl phosphinic acid, ethylene alkyl phosphinates and ethylene alkyl phosphinate
DE102008063642A1 (en) 2008-12-18 2010-06-24 Clariant International Limited Process for the preparation of monocarboxy-functionalized dialkylphosphinic acids, esters and salts by means of alkylene oxides and their use
DE102008063627A1 (en) 2008-12-18 2010-06-24 Clariant International Limited Process for the preparation of monohydroxy-functionalized dialkylphosphinic acids, esters and salts by means of ethylene oxide and their use
DE102008064003A1 (en) * 2008-12-19 2010-06-24 Clariant International Limited Process for the preparation of monofunctionalized dialkylphosphinic acids, esters and salts and their use
US20120016021A1 (en) 2010-07-15 2012-01-19 Xenoport, Inc. Methods of treating fragile x syndrome, down's syndrome, autism and related disorders
WO2020077186A1 (en) * 2018-10-12 2020-04-16 Icahn School Of Medicine At Mount Sinai Azd3355 (lesogaberan) for treatment and prevention of nonalcoholic steatohepatitis (nash), liver fibrosis, and other liver conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8911017D0 (en) * 1989-05-13 1989-06-28 Ciba Geigy Ag Substituted aminoalkylphosphinic acids
GB8912814D0 (en) * 1989-06-03 1989-07-19 Ciba Geigy Ag P-substituted propane-phospinic acid compounds
SE9603408D0 (en) * 1996-09-18 1996-09-18 Astra Ab Medical use

Also Published As

Publication number Publication date
WO2002100871A1 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
SE9904508D0 (en) New compounds
SE0102055D0 (en) New Compounds
ATE360630T1 (en) AZABICYCLIC HETEROCYCLES AS MODULATORS OF THE CANNABINOID RECEPTOR
MXPA03005464A (en) Antiviral agents.
PT1263725E (en) NEW COMPOUNDS
EP1248612A4 (en) Novel compounds and compositions as protease inhibitors
EE200100487A (en) Novel Compounds and Compositions as Protease Inhibitors
TNSN03110A1 (en) Azaindoles.
IS6658A (en) New compounds
MXPA02012033A (en) 2-aminocarbonyl-9h-purine derivatives.
SE0302760D0 (en) New compounds
SE0100569D0 (en) New compounds
NO20040589L (en) Arylsulfonyl derivatives with 5-HT6 receptor affinity.
SE0102440D0 (en) New compound
MXPA03010766A (en) Novel compounds and compositions as cathepsin inhibitors.
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
SE0102057D0 (en) New Salts I
DE60121048D1 (en) PYRAZINOi1&#39;2 &#39;: 1,6öPYRIDOi3,4-BöINDOLDERIVATE
SE0102058D0 (en) New Salts II
DE69828522D1 (en) ANTITROMOMBOTIC AGENTS
DE60103034D1 (en) NEW PHENYLHETEROALKYLAMINE DERIVATIVES
SE9900190D0 (en) New compounds
SE0403118D0 (en) New compounds 2
SE0403117D0 (en) New compounds 1
GEP20053513B (en) 2-Aminocarbonyl-9H-Purine Derivatives